ACMT Position Statement: Sterile Solution Shortage
- PMID: 39907986
- PMCID: PMC11933562
- DOI: 10.1007/s13181-025-01060-1
ACMT Position Statement: Sterile Solution Shortage
Conflict of interest statement
Declarations. Competing interests: The authors have no relevant financial or non-financial interests to disclose.
References
-
- Mazer-Amirshahi M, Fox ER, Zocchi MS, Pines JM, van den Anker JN. Longitudinal trends in U.S. shortages of sterile solutions, 2001-17. Am J Health Syst Pharm. 2018;75(23):1903–8. - PubMed
-
- Mazer-Amirshahi M, Fox ER. Saline shortages - many causes, no simple solution. N Engl J Med. 2018;378(16):1472–4. - PubMed
-
- U.S. Food and Drug Administration. Hurricane Helene: Baxter’s manufacturing recovery in North Carolina. https://www.fda.gov/drugs/updates-2024-hurricane-season/hurricane-helene.... Accessed December 15, 2024.
-
- Hick JL, Hanfling D, Courtney B, Lurie N. Rationing salt water–disaster planning and daily care delivery. N Engl J Med. 2014;370(17):1573–6. - PubMed
-
- Woodcock J, Wosinska M. Economic and technological drivers of generic sterile injectable drug shortages. Clin Pharmacol Ther. 2013;93(2):170–6. - PubMed
LinkOut - more resources
Full Text Sources
